Verenigde Staten - Engels - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - diethylpropion hydrochloride (unii: 19v2pl39ng) (diethylpropion - unii:q94yyu22b8) - diethylpropion hydrochloride is indicated in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (bmi) of 30 kg/m 2 or higher and who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone. below is a chart of bmi based on various heights and weights. bmi is calculated by taking the patient’s weight, in kilograms (kg), divided by the patient’s height, in meters (m), squared. metric conversions are as follows: pounds divided by 2.2 = kg; inches x 0.0254 = meters. the usefulness of agents of this class (see clinical pharmacology ) should be measured against possible risk factors inherent in their use such as those described below. diethylpropion hydrochloride is indicated for use as monotherapy only. pulmonary hypertension, advanced arteriosclerosis, hyperthyroidism, known hypersensitivity or idiosyncrasy to the sympathomimetic amines, glaucoma, severe hypertension. (see precautions .) agitated states. patients with a history of drug abuse. use in combination with other anorectic agents is contraindicated. during or within 14 days following the administration of monoamine oxidase inhibitors, hypertensive crises may result. diethylpropion hydrochloride is a schedule iv controlled substance. diethylpropion hydrochloride has some chemical and pharmacologic similarities to the amphetamines and other related stimulant drugs that have been extensively abused. there have been reports of subjects becoming psychologically dependent on diethylpropion. the possibility of abuse should be kept in mind when evaluating the desirability of including a drug as part of a weight reduction program. abuse of amphetamines and related drugs may be associated with varying degrees of psychologic dependence and social dysfunction which, in the case of certain drugs, may be severe. there are reports of patients who have increased the dosage to many times that recommended. abrupt cessation following prolonged high dosage administration results in extreme fatigue and mental depression; changes are also noted on the sleep eeg. manifestations of chronic intoxication with anorectic drugs include severe dermatoses, marked insomnia, irritability, hyperactivity, and personality changes. the most severe manifestation of chronic intoxication is psychosis, often clinically indistinguishable from schizophrenia.

Verenigde Staten - Engels - NLM (National Library of Medicine)

torrent pharmaceuticals limited - fluvoxamine maleate (unii: 5lgn83g74v) (fluvoxamine - unii:o4l1xpo44w) - fluvoxamine maleate 100 mg - fluvoxamine maleate extended-release capsules are indicated for the treatment of obsessive compulsive disorder (ocd), as defined in the dsm-iv. obsessive compulsive disorder is characterized by recurrent and persistent ideas, thoughts, impulses, or images (obsessions) that are ego-dystonic and/or repetitive, purposeful, and intentional behaviors (compulsions) that are recognized by the person as excessive or unreasonable. the obsessions or compulsions cause marked distress, are time-consuming, or significantly interfere with social or occupational functioning.  the efficacy of fluvoxamine maleate extended-release capsules was demonstrated in one 12-week trial in adults with fluvoxamine maleate extended-release capsules as well as in two 10-week trials in adults and in one 10-week trial in children and adolescents (ages 8 to 17 years) with immediate-release fluvoxamine tablets in outpatients with the diagnosis of ocd as defined in dsm-iv or dsm-iii-r (see clinical studies  [14.1, 14.3] ). the efficacy of fluv

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

*** company unknown *** - diethylcarbamazine citrate 50mg - tablet - 50 mg - active: diethylcarbamazine citrate 50mg

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

wyeth (nz) ltd - diethylcarbamazine citrate 50mg - tablet - 50 mg - active: diethylcarbamazine citrate 50mg

Australië - Engels - APVMA (Australian Pesticides and Veterinary Medicines Authority)

conquest crop protection pty ltd - mefenpyr-diethyl - unknown - mefenpyr-diethyl pyrazoline active 0.0 - active constituent

Australië - Engels - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bayer cropscience pty ltd - mefenpyr-diethyl - unknown - mefenpyr-diethyl pyrazoline active 0.0 - active constituent

Australië - Engels - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bayer cropscience pty ltd - mefenpyr-diethyl - unknown - mefenpyr-diethyl pyrazoline active 0.0 - active constituent

Australië - Engels - APVMA (Australian Pesticides and Veterinary Medicines Authority)

clariant (australia) pty ltd - diethyltoluamide - unknown - diethyltoluamide insect repellent active 0.0 - active constituent

Australië - Engels - APVMA (Australian Pesticides and Veterinary Medicines Authority)

vertellus llc - diethyltoluamide - unknown - diethyltoluamide insect repellent active 0.0 - active constituent

Australië - Engels - APVMA (Australian Pesticides and Veterinary Medicines Authority)

amtrade international pty ltd - diethyltoluamide - unknown - diethyltoluamide insect repellent active 0.0 - active constituent